167 related articles for article (PubMed ID: 11429395)
1. The effect of the beta(2) adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function.
Hoffstedt J; Iliadou A; Pedersen NL; Schalling M; Arner P
Br J Pharmacol; 2001 Jul; 133(5):708-12. PubMed ID: 11429395
[TBL] [Abstract][Full Text] [Related]
2. Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function.
Large V; Hellström L; Reynisdottir S; Lönnqvist F; Eriksson P; Lannfelt L; Arner P
J Clin Invest; 1997 Dec; 100(12):3005-13. PubMed ID: 9399946
[TBL] [Abstract][Full Text] [Related]
3. Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells.
Lönnqvist F; Wahrenberg H; Hellström L; Reynisdottir S; Arner P
J Clin Invest; 1992 Dec; 90(6):2175-86. PubMed ID: 1334970
[TBL] [Abstract][Full Text] [Related]
4. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells.
Rydén M; Faulds G; Hoffstedt J; Wennlund A; Arner P
Diabetes; 2002 May; 51(5):1601-8. PubMed ID: 11978662
[TBL] [Abstract][Full Text] [Related]
5. In vivo interactions between beta-1 and beta-2 adrenoceptors regulate catecholamine tachyphylaxia in human adipose tissue.
Arner P; Kriegholm E; Engfeldt P
J Pharmacol Exp Ther; 1991 Oct; 259(1):317-22. PubMed ID: 1681086
[TBL] [Abstract][Full Text] [Related]
6. Association of a beta-2 adrenoceptor (ADRB2) gene variant with a blunted in vivo lipolysis and fat oxidation.
Jocken JW; Blaak EE; Schiffelers S; Arner P; van Baak MA; Saris WH
Int J Obes (Lond); 2007 May; 31(5):813-9. PubMed ID: 17130852
[TBL] [Abstract][Full Text] [Related]
7. Human beta2-adrenergic receptor gene haplotypes and venodilation in vivo.
Bruck H; Leineweber K; Park J; Weber M; Heusch G; Philipp T; Brodde OE
Clin Pharmacol Ther; 2005 Sep; 78(3):232-8. PubMed ID: 16153394
[TBL] [Abstract][Full Text] [Related]
8. The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis.
Rydén M; Hoffstedt J; Eriksson P; Bringman S; Arner P
Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1599-603. PubMed ID: 11753577
[TBL] [Abstract][Full Text] [Related]
9. Blunted beta-adrenoceptor-mediated fat oxidation in overweight subjects: a role for the hormone-sensitive lipase gene.
Jocken JW; Blaak EE; van der Kallen CJ; van Baak MA; Saris WH
Metabolism; 2008 Mar; 57(3):326-32. PubMed ID: 18249203
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of an in vivo functional beta 3-adrenoceptor in man.
Enocksson S; Shimizu M; Lönnqvist F; Nordenström J; Arner P
J Clin Invest; 1995 May; 95(5):2239-45. PubMed ID: 7738189
[TBL] [Abstract][Full Text] [Related]
11. Multiple lipolysis defects in the insulin resistance (metabolic) syndrome.
Reynisdottir S; Ellerfeldt K; Wahrenberg H; Lithell H; Arner P
J Clin Invest; 1994 Jun; 93(6):2590-9. PubMed ID: 8200997
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine-induced adipocyte lipolysis in human hyperthyroidism.
Hellström L; Wahrenberg H; Reynisdottir S; Arner P
J Clin Endocrinol Metab; 1997 Jan; 82(1):159-66. PubMed ID: 8989252
[TBL] [Abstract][Full Text] [Related]
13. Influence of sex and beta2 adrenergic receptor haplotype on resting and terbutaline-stimulated whole body lipolysis.
Lima JJ; Mauras N; Kissoon N; Wang J; Wiltrout SA; Sylvester JE
Metabolism; 2005 Apr; 54(4):492-9. PubMed ID: 15798957
[TBL] [Abstract][Full Text] [Related]
14. Noradrenaline-induced lipolysis in isolated mesenteric, omental and subcutaneous adipocytes from obese subjects.
Van Harmelen V; Lönnqvist F; Thörne A; Wennlund A; Large V; Reynisdottir S; Arner P
Int J Obes Relat Metab Disord; 1997 Nov; 21(11):972-9. PubMed ID: 9368819
[TBL] [Abstract][Full Text] [Related]
15. Regulation of lipolysis in fat cells of obese women during long-term hypocaloric diet.
Hellström L; Reynisdottir S; Langin D; Rössner S; Arner P
Int J Obes Relat Metab Disord; 1996 Aug; 20(8):745-52. PubMed ID: 8856398
[TBL] [Abstract][Full Text] [Related]
16. In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.
Barbe P; Millet L; Galitzky J; Lafontan M; Berlan M
Br J Pharmacol; 1996 Mar; 117(5):907-13. PubMed ID: 8851509
[TBL] [Abstract][Full Text] [Related]
17. Lipolytic effects of beta1, beta2 and beta3-adrenergic agonists in isolated human fat cells from omental and retroperitoneal adipose tissues.
Portillo MP; Rocandio AM; Garcia-Calonge MA; Diaz E; Campo E; Martinez-Blazquez C; Errasti J; del Barrio AS
Rev Esp Fisiol; 1995 Dec; 51(4):193-200. PubMed ID: 8907433
[TBL] [Abstract][Full Text] [Related]
18. Lipolytic catecholamine resistance linked to alpha 2-adrenoceptor sensitivity--a metabolic predictor of weight loss in obese subjects.
Hellström L; Rössner S; Hagström-Toft E; Reynisdottir S
Int J Obes Relat Metab Disord; 1997 Apr; 21(4):314-20. PubMed ID: 9130030
[TBL] [Abstract][Full Text] [Related]
19. Relationship between beta-2 adrenoceptor gene haplotypes and adipocyte lipolysis in women.
Eriksson P; Dahlman I; Rydén M; Hoffstedt J; Arner P
Int J Obes Relat Metab Disord; 2004 Feb; 28(2):185-90. PubMed ID: 14610528
[TBL] [Abstract][Full Text] [Related]
20. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity.
Lönnqvist F; Thöme A; Nilsell K; Hoffstedt J; Arner P
J Clin Invest; 1995 Mar; 95(3):1109-16. PubMed ID: 7883959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
